This is an abbreviated version of Battea’s Endo International securities litigation proprietary research. Full case summaries and economic analyses are available to clients through Battea’s litigation monitoring portal. For more information, or to request a demonstration, contact Battea.
Case Filed: March 31, 2017
Class action on behalf of persons or entities that purchased or otherwise acquired Endo common stock pursuant to the company's registration statement issued in connection with the June 5, 2015 secondary public offering of common stock pursuant to sections 11, 12(a) and 15 of the Securities Act of 1933. To read more about the Endo International securities litigation, visit Battea's Endo International news article.
|Lead Plaintiff Deadline||5/30/2017
The complaint alleges that rather than disclose the eroding market for Endo's most important generic medications, the Prospectus stated that Endo's generic division was capitalizing on encouraging demand trends for a different portfolio of controlled substances and liquids.
Brief Company Profile
Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Its U.S. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
|Class Period||June 5, 2015 Secondary Public Offering
|Court||Supreme Ct of PA
|Plaintiff(s)||Public Employees' Retirement System of Mississippi
|Defendant(s)||ENDO INTERNATIONAL PLC; RAJIV KANISHKA
LIYANAARCHCHIE DE SILVA; SUKETU P.
UPADHYAY; DANIEL A. RUDIO; ROGER H.
KIMMEL; SHANE M. COOKE; JOHN J. DELUCCA;
ARTHUR J. HIGGINS; NANCY J. HUTSON; MICHAEL
HYATT; WILLIAM P. MONTAGUE; JILL D.
SMITH; WILLIAM F. SPENGLER; GOLDMAN,
SACHS & CO.; J.P. MORGAN SECURITIES LLC;
BARCLAYS CAPITAL INC.; DEUTSCHE BANK
SECURITIES INC.; RBC CAPITAL MARKETS, LLC;
CITIGROUP GLOBAL MARKETS, LLC; MORGAN
STANLEY & CO. LLC; SUNTRUST ROBINSON
HUMPHREY, INC.; TD SECURITIES (USA) LLC;
and MITSUBISHI UFJ SECURITIES (USA) INC.,
Endo International Securities Litigation Price Chart